Normax Biomed

Cork, Ireland

Normax Biomed is an mRNA Vaccine research and development and manufacturing company.

$301.4M raised

Jul 2022

Venture - Series Unknown

Biotechnology Manufacturing Pharmaceutical

Top Investors

The Global Emerging Markets Group

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Normax Biomed

How much funding has Normax Biomed raised?

Normax Biomed has raised $301.4M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2022.

Who are Normax Biomed's investors?

Normax Biomed's investors include The Global Emerging Markets Group.

Where is Normax Biomed headquartered?

Normax Biomed is headquartered in Cork, Ireland.

What does Normax Biomed do?

Normax Biomed is an mRNA Vaccine research and development and manufacturing company.

What stage is Normax Biomed at?

Normax Biomed is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 11, 2022.

MLA

"Normax Biomed — Funding & Investors." VCBacked, July 11, 2022, https://www.vcbacked.co/company/normax-biomed. Accessed July 2, 2026.

APA

VCBacked. (2022). Normax Biomed — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/normax-biomed

Wikipedia (cite web)

{{cite web |title=Normax Biomed — Funding & Investors |url=https://www.vcbacked.co/company/normax-biomed |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 11, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K